Han‐Kwang Yang

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

Yung‐Jue Bang, Young‐Woo Kim, Han‐Kwang Yang et al. · The Lancet · 2012 · 1.7K citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +10

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Sung Hoon Noh, Sook Ryun Park, Han‐Kwang Yang et al. · The Lancet Oncology · 2014 · 1K citations · Full text

Gastrointestinal Oncology, Medicine, Randomised Phase 3 +7

Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial

Kazumasa Fujitani, Han‐Kwang Yang, Junki Mizusawa et al. · The Lancet Oncology · 2016 · 688 citations

Single Non-curable Factor, Surgical Oncology, Gastrointestinal Oncology +8

Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer

Wook Kim, Hyung‐Ho Kim, Sang‐Uk Han et al. · Annals of Surgery · 2015 · 623 citations

Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Outgrowth Endothelial Cells

Chang‐Hwan Yoon, Jin Hur, Kyung Woo Park et al. · Circulation · 2005 · 590 citations